Previous researches have confirmed that nanoscale Mn3O4 could present multi-enzyme-like behavior, including SOD-like, catalase (CAT)-like and ·OH scavenging activities in the medication of ROS-related diseases, including inflammatory bowel diseases, acute kidney injury, cardiovascular and cerebrovascular diseases, and other tissue inflammation [18–21]. This evidence concerns the gene CAT and acute kidney injury.